| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0028 | 1 |